Section Arrow
IMCR.NASDAQ
- Immunocore Holdings plc
Quotes are at least 15-min delayed:2024/10/31 19:27 EDT
Last
 30.83
-1.08 (-3.38%)
Day High 
31.945 
Prev. Close
31.91 
1-M High
35.47 
Volume 
180.94K 
Bid
30.76
Ask
33.2
Day Low
30.53 
Open
31.77 
1-M Low
29.72 
Market Cap 
1.60B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 33 
20-SMA 32.14 
50-SMA 33.09 
52-W High 76.98 
52-W Low 29.72 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.10/-2.74
Enterprise Value
1.68B
Balance Sheet
Book Value Per Share
7.18
Cash Flow
Cash Flow Yield
0.01
Income Statement
Total Revenue
249.43M
Operating Revenue Per Share
0.83
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ELABElevai Labs0.059-0.0339-36.49%-- 
AVTEAerovate Therapeutics2.46+0.27+12.33%-- 
ENSCEnsysce Biosciences0.5754-0.0629-9.85%-- 
TNXPTonix Pharmaceuticals Holding Corp.0.1445-0.0099-6.41%-- 
GLYCGlycoMimetics0.4069-0.0496-10.87%-- 
Quotes are at least 15-min delayed:2024/10/31 19:27 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.